{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:34:57Z","timestamp":1783726497460,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11418-023-01723-9","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T17:01:51Z","timestamp":1688144511000},"page":"953-963","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fucoxanthin exert dose-dependent antifibrotic and anti-inflammatory effects on CCl4-induced liver fibrosis"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3967-0442","authenticated-orcid":false,"given":"Vasilii N.","family":"Slautin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5698-8404","authenticated-orcid":false,"given":"Dmitry Yu.","family":"Grebnev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-7947","authenticated-orcid":false,"given":"Irina Yu.","family":"Maklakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7064-0079","authenticated-orcid":false,"given":"Sergey V.","family":"Sazonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"key":"1723_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2021.730176","volume":"9","author":"Z Tan","year":"2021","unstructured":"Tan Z, Sun H, Xue T et al (2021) Liver fibrosis: therapeutic targets and advances in drug therapy. Front Cell Dev Biol 9:1\u201318. https:\/\/doi.org\/10.3389\/fcell.2021.730176","journal-title":"Front Cell Dev Biol"},{"key":"1723_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/TP.0000000000003550","volume":"105","author":"CJ Karvellas","year":"2021","unstructured":"Karvellas CJ, Francoz C, Weiss E (2021) Liver transplantation in acute-on-chronic liver failure. Transplantation 105:1471\u20131481. https:\/\/doi.org\/10.1097\/TP.0000000000003550","journal-title":"Transplantation"},{"key":"1723_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D (2021) Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 18:151\u2013166. https:\/\/doi.org\/10.1038\/s41575-020-00372-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1723_CR4","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.drudis.2021.12.012","volume":"27","author":"K Baghaei","year":"2022","unstructured":"Baghaei K, Mazhari S, Tokhanbigli S et al (2022) Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis. Drug Discov Today 27:1044\u20131061. https:\/\/doi.org\/10.1016\/j.drudis.2021.12.012","journal-title":"Drug Discov Today"},{"key":"1723_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu CC, Troeger JS et al (2013) Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun 4:1\u201311. https:\/\/doi.org\/10.1038\/ncomms3823","journal-title":"Nat Commun"},{"key":"1723_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y (2017) Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 121:27\u201342. https:\/\/doi.org\/10.1016\/j.addr.2017.05.007","journal-title":"Adv Drug Deliv Rev"},{"key":"1723_CR7","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","volume":"67","author":"CR Gandhi","year":"2017","unstructured":"Gandhi CR (2017) Hepatic stellate cell activation and pro-fibrogenic signals. J Hepatol 67:1104\u20131105. https:\/\/doi.org\/10.1016\/j.jhep.2017.06.001","journal-title":"J Hepatol"},{"key":"1723_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.bbrc.2019.04.052","volume":"513","author":"M Kim","year":"2019","unstructured":"Kim M, Bae M, Hu S et al (2019) Fucoxanthin exerts anti-fibrogenic effects in hepatic stellate cellsBo. Biochem Biophys Res Commun 513:657\u2013662. https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.052","journal-title":"Biochem Biophys Res Commun"},{"key":"1723_CR9","doi-asserted-by":"publisher","first-page":"100245","DOI":"10.1016\/j.jafr.2021.100245","volume":"6","author":"Y Li","year":"2021","unstructured":"Li Y, Kim MB, Park YK, Lee JY (2021) Fucoxanthin metabolites exert anti-fibrogenic and antioxidant effects in hepatic stellate cells. J Agric Food Res 6:100245. https:\/\/doi.org\/10.1016\/j.jafr.2021.100245","journal-title":"J Agric Food Res"},{"key":"1723_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.929442","volume":"13","author":"M Mumu","year":"2022","unstructured":"Mumu M, Das A, Bin ET et al (2022) Fucoxanthin: a promising phytochemical on diverse pharmacological targets. Front Pharmacol 13:1\u201325. https:\/\/doi.org\/10.3389\/fphar.2022.929442","journal-title":"Front Pharmacol"},{"key":"1723_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bbrc.2020.05.050","volume":"528","author":"N Takatani","year":"2020","unstructured":"Takatani N, Kono Y, Beppu F et al (2020) Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice. Biochem Biophys Res Commun 528:305\u2013310. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.050","journal-title":"Biochem Biophys Res Commun"},{"key":"1723_CR12","doi-asserted-by":"publisher","first-page":"174629","DOI":"10.1016\/j.ejphar.2021.174629","volume":"913","author":"G Yang","year":"2021","unstructured":"Yang G, Li Q, Peng J et al (2021) Fucoxanthin regulates Nrf2 signaling to decrease oxidative stress and improves renal fibrosis depending on Sirt1 in HG-induced GMCs and STZ-induced diabetic rats. Eur J Pharmacol 913:174629. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174629","journal-title":"Eur J Pharmacol"},{"key":"1723_CR13","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1007\/s11356-017-0661-3","volume":"25","author":"J Zeng","year":"2018","unstructured":"Zeng J, Zhang Y, Ruan J et al (2018) Protective effects of fucoxanthin and fucoxanthinol against tributyltin-induced oxidative stress in HepG2 cells. Environ Sci Pollut Res 25:5582\u20135589. https:\/\/doi.org\/10.1007\/s11356-017-0661-3","journal-title":"Environ Sci Pollut Res"},{"key":"1723_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.00906","volume":"10","author":"J Su","year":"2019","unstructured":"Su J, Guo K, Huang M et al (2019) Fucoxanthin, a marine xanthophyll isolated from Conticribra weissflogii ND-8: preventive anti-inflammatory effect in a mouse model of sepsis. Front Pharmacol 10:1\u201317. https:\/\/doi.org\/10.3389\/fphar.2019.00906","journal-title":"Front Pharmacol"},{"key":"1723_CR15","doi-asserted-by":"publisher","first-page":"105119","DOI":"10.1016\/j.jff.2022.105119","volume":"94","author":"Z Deng","year":"2022","unstructured":"Deng Z, Wang J, Wu N et al (2022) Co-activating the AMPK signaling axis by low molecular weight fucoidan LF2 and fucoxanthin improves the HFD-induced metabolic syndrome in mice. J Funct Foods 94:105119. https:\/\/doi.org\/10.1016\/j.jff.2022.105119","journal-title":"J Funct Foods"},{"key":"1723_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ejphar.2010.09.032","volume":"649","author":"KN Kim","year":"2010","unstructured":"Kim KN, Heo SJ, Yoon WJ et al (2010) Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-\u03baB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages. Eur J Pharmacol 649:369\u2013375. https:\/\/doi.org\/10.1016\/j.ejphar.2010.09.032","journal-title":"Eur J Pharmacol"},{"key":"1723_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/md17100552","author":"J Zheng","year":"2019","unstructured":"Zheng J, Tian X, Zhang W et al (2019) Protective effects of fucoxanthin against alcoholic liver injury by activation of Nrf2-Mediated antioxidant defense and inhibition of TLR4-mediated inflammation. Mar Drugs. https:\/\/doi.org\/10.3390\/md17100552","journal-title":"Mar Drugs"},{"key":"1723_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cbi.2010.05.006","volume":"186","author":"MN Woo","year":"2010","unstructured":"Woo MN, Jeon SM, Kim HJ et al (2010) Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL\/6N mice. Chem Biol Interact 186:316\u2013322. https:\/\/doi.org\/10.1016\/j.cbi.2010.05.006","journal-title":"Chem Biol Interact"},{"key":"1723_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejphar.2017.06.022","volume":"811","author":"SY Ma","year":"2017","unstructured":"Ma SY, Park WS, Lee DS et al (2017) Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo. Eur J Pharmacol 811:199\u2013207. https:\/\/doi.org\/10.1016\/j.ejphar.2017.06.022","journal-title":"Eur J Pharmacol"},{"key":"1723_CR20","doi-asserted-by":"publisher","first-page":"103709","DOI":"10.1016\/j.jff.2019.103709","volume":"64","author":"M Terasaki","year":"2020","unstructured":"Terasaki M, Kuramitsu Y, Kojoma M et al (2020) High fucoxanthin wakame (Undaria pinnatifida) prevents tumor microenvironment formation in an AOM\/DSS mouse carcinogenic model. J Funct Foods 64:103709. https:\/\/doi.org\/10.1016\/j.jff.2019.103709","journal-title":"J Funct Foods"},{"key":"1723_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11010-009-0231-1","volume":"333","author":"RK Sangeetha","year":"2010","unstructured":"Sangeetha RK, Bhaskar N, Divakar S, Baskaran V (2010) Bioavailability and metabolism of fucoxanthin in rats: structural characterization of metabolites by LC-MS (APCI). Mol Cell Biochem 333:299\u2013310. https:\/\/doi.org\/10.1007\/s11010-009-0231-1","journal-title":"Mol Cell Biochem"},{"key":"1723_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1017\/S0007114508199007","volume":"102","author":"T Hashimoto","year":"2009","unstructured":"Hashimoto T, Ozaki Y, Taminato M et al (2009) The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice. Br J Nutr 102:242\u2013248. https:\/\/doi.org\/10.1017\/S0007114508199007","journal-title":"Br J Nutr"},{"key":"1723_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2131\/jts.34.501","volume":"34","author":"F Beppu","year":"2009","unstructured":"Beppu F, Niwano Y, Tsukui T et al (2009) Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice. J Toxicol Sci 34:501\u2013510. https:\/\/doi.org\/10.2131\/jts.34.501","journal-title":"J Toxicol Sci"},{"key":"1723_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0976-500X.72350","volume":"1","author":"S Parasuraman","year":"2010","unstructured":"Parasuraman S, Raveendran R, Kesavan R (2010) Blood sample collection in small laboratory animals. J Pharmacol Pharmacother 1:87\u201393. https:\/\/doi.org\/10.4103\/0976-500X.72350","journal-title":"J Pharmacol Pharmacother"},{"key":"1723_CR25","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1007\/s11064-016-1989-7","volume":"41","author":"Y Liu","year":"2016","unstructured":"Liu Y, Zheng J, Zhang Y et al (2016) Fucoxanthin activates apoptosis via inhibition of PI3K\/Akt\/mTOR pathway and suppresses invasion and migration by restriction of p38-MMP-2\/9 pathway in human glioblastoma cells. Neurochem Res 41:2728\u20132751. https:\/\/doi.org\/10.1007\/s11064-016-1989-7","journal-title":"Neurochem Res"},{"key":"1723_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3402\/fnr.v60.32033","volume":"60","author":"PA Hwang","year":"2016","unstructured":"Hwang PA, Phan NN, Lu WJ et al (2016) Low-molecular-weight fucoidan and high-stability fucoxanthin from brown seaweed exert prebiotics and anti-inflammatory activities in Caco-2 cells. Food Nutr Res 60:1\u20139. https:\/\/doi.org\/10.3402\/fnr.v60.32033","journal-title":"Food Nutr Res"},{"key":"1723_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu14091902","volume":"14","author":"M Bae","year":"2022","unstructured":"Bae M, Kim MB, Lee JY (2022) Fucoxanthin attenuates the reprogramming of energy metabolism during the activation of hepatic stellate cells. Nutrients 14:1\u20139. https:\/\/doi.org\/10.3390\/nu14091902","journal-title":"Nutrients"},{"key":"1723_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-804274-8.00029-1","author":"LE G\u00f3mez-Quiroz","year":"2017","unstructured":"G\u00f3mez-Quiroz LE, Guti\u00e9rrez-Ruiz MC, Marquardt JU et al (2017) Redox regulation by HGF\/c-Met in liver disease. Liver Pathophysiol Ther Antioxidants. https:\/\/doi.org\/10.1016\/B978-0-12-804274-8.00029-1","journal-title":"Liver Pathophysiol Ther Antioxidants"},{"key":"1723_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00210-020-01891-5","volume":"394","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wang Y, Zhu G et al (2021) Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride\u2013induced liver fibrosis in mice. Naunyn Schmiedebergs Arch Pharmacol 394:189\u2013204. https:\/\/doi.org\/10.1007\/s00210-020-01891-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1723_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2017.02.057","volume":"486","author":"N Yang","year":"2017","unstructured":"Yang N, Dang S, Shi J et al (2017) Caffeic acid phenethyl ester attenuates liver fibrosis via inhibition of TGF-\u03b21\/Smad3 pathway and induction of autophagy pathway. Biochem Biophys Res Commun 486:22\u201328. https:\/\/doi.org\/10.1016\/j.bbrc.2017.02.057","journal-title":"Biochem Biophys Res Commun"},{"key":"1723_CR31","doi-asserted-by":"publisher","first-page":"56267","DOI":"10.18632\/oncotarget.17453","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L, Dong X, Wang L et al (2017) Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-\u03b2\/Smad signaling pathway. Oncotarget 8:56267\u201356280. https:\/\/doi.org\/10.18632\/oncotarget.17453","journal-title":"Oncotarget"},{"key":"1723_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4490\/algae.2014.29.4.355","volume":"29","author":"VT Nguyen","year":"2014","unstructured":"Nguyen VT, Qian ZJ, Lee B et al (2014) Fucoxanthin derivatives from Sargassum siliquastrum inhibit matrix metalloproteinases by suppressing NF-kB and MAPKs in human fibrosarcoma cells. Algae 29:355\u2013366. https:\/\/doi.org\/10.4490\/algae.2014.29.4.355","journal-title":"Algae"},{"key":"1723_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20061295","volume":"20","author":"RPH Meier","year":"2019","unstructured":"Meier RPH, Meyer J, Montanari E et al (2019) Interleukin-1 receptor antagonist modulates liver inflammation and fibrosis in mice in a model-dependent manner. Int J Mol Sci 20:1\u201318. https:\/\/doi.org\/10.3390\/ijms20061295","journal-title":"Int J Mol Sci"},{"key":"1723_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/md19070354","volume":"19","author":"L Pistelli","year":"2021","unstructured":"Pistelli L, Sansone C, Smerilli A et al (2021) Mmp-9 and il-1\u03b2 as targets for diatoxanthin and related microalgal pigments: potential chemopreventive and photoprotective agents. Mar Drugs 19:1\u201318. https:\/\/doi.org\/10.3390\/md19070354","journal-title":"Mar Drugs"},{"key":"1723_CR35","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki E, Schwabe RF (2015) Hepatic inflammation and fibrosis: Functional links and key pathways. Hepatology 61:1066\u20131079. https:\/\/doi.org\/10.1002\/hep.27332","journal-title":"Hepatology"},{"key":"1723_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/nu14112280","author":"MB Kim","year":"2022","unstructured":"Kim MB, Bae M, Lee Y et al (2022) Consumption of low dose fucoxanthin does not prevent hepatic and adipose inflammation and fibrosis in mouse models of diet-induced obesity. Nutrients. https:\/\/doi.org\/10.3390\/nu14112280","journal-title":"Nutrients"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-023-01723-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-023-01723-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-023-01723-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T10:14:08Z","timestamp":1693304048000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-023-01723-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1723"],"URL":"https:\/\/doi.org\/10.1007\/s11418-023-01723-9","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,30]]},"assertion":[{"value":"14 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}